Meghana R. K. Helder, MD, Nicholas T

Slides:



Advertisements
Similar presentations
Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Advertisements

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
A cherry blossom moment in the history of heart valve replacement
Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: A word of caution  Pankaj Saxena, FRACS, PhD, Kevin L. Greason,
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N
Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results  Kenton J. Zehr,
Antegrade thoracic stent grafting during repair of acute Debakey type I dissection promotes distal aortic remodeling and reduces late open distal reoperation.
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,
Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis  Evaldas Girdauskas,
Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing  Jess L. Thompson, MD, Harold M. Burkhart, MD,
Right internal thoracic artery or saphenous vein grafting
Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation  John M. Stulak, MD, Joseph A. Dearani, MD, Thoralf.
Hirokazu Fujimoto, MD, PhD, Meghana R. K
Exposed thoracic aortic endovascular stent graft
Form ever follows function
Supracoronary ascending aortic replacement in patients with acute aortic dissection type A: What happens to the aortic root in the long run?  Bartosz.
It is still mostly about the mitral valve
Quadruple valve replacement in patients with carcinoid heart disease
Bicuspid aortic valve aortopathy: One size fits all?
Outcome of Surgical Repair of Pulmonary Artery Aneurysms: A Single-Center Experience With 38 Patients  Janani S. Reisenauer, MD, Sameh M. Said, MD, Hartzell.
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Vikas Sharma, MBBS, Rakesh M. Suri, MD, DPhil, Joseph A
Pathologic features of cryopreserved aortic allograft implanted in the active infection  Akitoshi Yamada, MD, Kenji Okada, MD, Rei Takahashi, MD, Yutaka.
Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design
It's not “just a shunt” but sometimes it should be…
Michele Gallo, MD, Gino Gerosa, MD 
Apicoaortic conduit in a patient with severe aortic stenosis: An alternative to transcutaneous aortic valve implantation  Sotiris C. Stamou, MD, Nicholas.
Eyad K. El-Najdawi, MDa, David J. Driscoll, MDa, Francisco J
The aortic valve–sparing operation
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Open thoracoabdominal aortic repair for chronic type B dissection
When should a mechanical tricuspid valve replacement be considered?
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
A cherry blossom moment in the history of heart valve replacement
Valve-sparing root reimplantation and leaflet repair in a bicuspid aortic valve: Comparison with the 3-cusp David procedure  Joseph E. Bavaria, MD, Nimesh.
A case of chest wall angiosarcoma associated with breast implants
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
In search of the smoking gun in calcific aortic valve disease
Replicating the success of mitral valve repair in the aortic valve
A fate worse than death  Jennifer S. Lawton, MD 
Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation  Aaron Martin, MD, Michael.
Cardiac myxoma: Simplifying a “complex” case
Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients  Anita Nguyen, MBBS, C. Christopher Hook, MD, Joseph.
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Sutureless valve implantation: Every detail counts
Biomaterials for heart valve replacement: Conjectures and refutations
Postimplantation morphologic changes of glutaraldehyde-fixed porcine aortic roots and risk of aneurysm and rupture  Tirone E. David, MD, Susan Armstrong,
Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: A propensity-matched analysis of 2 strategies in high-risk patients 
Hans-Joachim Schäfers, MD 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Concomitant replacement of the ascending aorta is free—for some
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome  Jess L. Thompson, MD, Hartzell V. Schaff,
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Clinical outcomes and fate of the distal aorta following 1-stage repair of extensive chronic thoracic aortic dissection  Nicholas T. Kouchoukos, MD, Alexander.
“The more things change…”: The challenges ahead
John M. Stulak, MD, Joseph A. Dearani, MD, Harold M
Toward a more rational approach in treating type B aortic dissection
Left atrial to left ventricle bypass for mitral valve stenosis
Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Presentation transcript:

Late durability of decellularized allografts for aortic valve replacement: A word of caution  Meghana R.K. Helder, MD, Nicholas T. Kouchoukos, MD, Kenton Zehr, MD, Joseph A. Dearani, MD, Joseph J. Maleszewski, MD, Charles Leduc, MD, Courtney N. Heins, BS, Hartzell V. Schaff, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 152, Issue 4, Pages 1197-1199 (October 2016) DOI: 10.1016/j.jtcvs.2016.03.050 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Histopathologic findings of DAVAs in tissue sections stained with hematoxylin and eosin (left column) and corresponding Verhoeff-Van Gieson elastic (right column) stains, showing (A and B) full-thickness degeneration of the valve cusp and (C and D) marked calcification of the tubular component of the graft. (Original magnification, 40×.) The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1197-1199DOI: (10.1016/j.jtcvs.2016.03.050) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan-Meier curves for freedom from reoperation. Patients implanted with a DAVA had a 92% (95% CI, 84%-100%) freedom from reoperation at 5 years postimplantation, compared with 100% in the control group. Freedom from reoperation at 10 years postoperatively was 51% (95% CI, 34%-76%) in patients receiving a DAVA, compared with 80% (95% CI, 60%-100%) in the control group (P = .06). The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1197-1199DOI: (10.1016/j.jtcvs.2016.03.050) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Kaplan-meier curves for freedom from reoperation Kaplan-meier curves for freedom from reoperation. Curves vary significantly at 10 years (P = .06). The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1197-1199DOI: (10.1016/j.jtcvs.2016.03.050) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions